2
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Vomiting
1
Neoplasms
1
Nausea
1
Breast Neoplasms
1
Interventions
Dexamethasone
51
Aprepitant
39
Palonosetron
37
Ondansetron
31
Granisetron
22
Calcium Dobesilate
14
fosaprepitant
13
Olanzapine
13
Therapeutics
8
dexamethasone acetate
7
ramosetron
6
netupitant, palosentron drug combination
6
casopitant
6
Tropisetron
6
Cyclophosphamide
6
dexamethasone 21-phosphate
5
Radiotherapy
5
Metoclopramide
5
Doxorubicin
5
netupitant
4
dolasetron
4
Surveys and Questionnaires
4
Dronabinol
4
Acupressure
4
Yoga
3
Vincristine
3
Tablets
3
Psychiatric Rehabilitation
3
Prochlorperazine
3
Lorazepam
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Vomiting
×
alizapride
×
Clear all
NCT01636947
2018-09-25
KMEC
Merck Sharp & Dohme LLC
Phase 4
Completed
494 enrolled
14 charts